OTC Markets OTCQB USD
Panbela Therapeutics, Inc. (PBLA)
At close: 3:07 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -41.2 | -217 | -1.62 | -1.7 |
| EPS Actual | -53.8 | -65.9 | -2.28 | -1.47 |
| Difference | -12.6 | 151.1 | -0.66 | 0.23 |
| Surprise % | -30.58% | 69.63% | -40.74% | 13.27% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PBLA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.00% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | -- | -- | -- | 2.10% |
| Next Year | -- | -- | -- | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral | 8/15/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 6/24/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/16/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/2/2024 |
| Maintains | Roth MKM: Buy to Buy | 3/27/2024 |
| Maintains | Roth MKM: Buy to Buy | 2/5/2024 |
Related Tickers
ENTO Entero Therapeutics, Inc.
0.4533
+9.23%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
NEXI NexImmune, Inc.
0.3000
+36.24%
PCSA Processa Pharmaceuticals, Inc.
0.8601
-2.26%
EVFM Evofem Biosciences, Inc.
0.0100
+2.04%
DRMA Dermata Therapeutics, Inc.
1.1371
-3.64%
AVTE Aerovate Therapeutics, Inc.
2.6600
+1.92%
AJ8.MU Agenus Inc
2.6400
+3.13%
UQ1.F uniQure N.V.
5.38
+3.14%
1U5.F Wave Life Sciences Ltd.
13.60
+1.49%